A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol

Contraception

Volumn 59, Issue 5, 1999, Pages 305-310

  Weisberg, Edith ^a,b   Fraser, Ian S ^a,b   Mishell Jr, Daniel R ^c   Lacarra, Maria ^c   Darney, Phillip ^d   Jackanicz, Theodore M ^e  

^a FAMILY PLANNING NSW   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e POPULATION COUNCIL   (United States)

Author keywords

Contraceptive vaginal rings; Ethinyl estradiol; Norethindrone acetate

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE;

ABDOMINAL CRAMP; ACNE; ADULT; ARTICLE; BACKACHE; BODY WEIGHT; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INTRAVAGINAL DRUG ADMINISTRATION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MENSTRUATION DISORDER; MULTICENTER STUDY; NAUSEA; NORMAL HUMAN; PATIENT COMPLIANCE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VAGINA CONTRACEPTION; VAGINA RING; VERTIGO; VOMITING;

AMERICAS; AUSTRALIA; CALIFORNIA; CLINICAL RESEARCH--WOMEN; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, ESTROGEN; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; ETHINYL ESTRADIOL; FAMILY PLANNING; NORETHINDRONE; NORETHINDRONE ACETATE; NORTH AMERICA; NORTHERN AMERICA; OCEANIA; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; UNITED STATES; VAGINAL RINGS; WOMEN;

ADOLESCENT; ADULT; BIOCOMPATIBLE MATERIALS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; CORPUS LUTEUM; DELAYED-ACTION PREPARATIONS; ELASTOMERS; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; HUMANS; NORETHINDRONE; OVARIAN FOLLICLE; OVARY; PROGESTERONE; SILICONES; VAGINA;

EID: 0032866649     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00036-0     Document Type: Article

References (14)

1. Shoupe D., Mishell D.R. Jr. Contraceptive vaginal rings efficacy and acceptability . Sitruk-Ware R., Bardin C.W. Contraception Newer Pharmacological Agents, Devices and Delivery Systems . 1992;71-89 Marcel Dekker, New York.
2. Mishell D.R. Jr, Moore D.E., Roy S., Brenner P.F., Page M.A. Clinical performance and endocrine profiles with contraceptive rings containing a combination of estradiol and d-norgestrel. Am J Obstet Gynecol. 24:1978;451-468.
3. Ballagh S.A., Mishell D.R. Jr, Lacarra M., et al. A contraceptive vaginal ring releasing norethindrone acetate and ethynyl estradiol. Contraception. 50:1994;517-533.
4. Ballagh S.A., Mishell D.R. Jr, Jackanicz T.M., Lacarra M., Eggins P. Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol. Contraception. 50:1994;535-549.
5. Manual for the Standardisation of Colposcopy for the Evaluation of Vaginally Administered Products. 1996;15 World Health Organization, Geneva.
6. Fraser IS, Lacarra M, Mishell DR Jr, Alvarez F. et al. Vaginal epithelial surface appearances in women using vaginal rings for contraception. Submitted for publication.
7. Price T.M., Dupuis R.E., Carr B.R., Stanczyk F.Z., Lobo R.A., Droegemueller W. Single and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. Am J Obstet Gynecol. 168:1993;1400-1406.
8. Stanczyk F.Z., Brenner P.F., Mishell D.R. Jr, Ortiz A., Gentzschein E.K.E., Goebelsman U.A. Radioimmunoassay for norethindrone (NET) measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids . Contraception. 18:1978;615-633.
9. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:1973;476-482.
10. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
11. Landgren B.-M., Diczfalusy E. Hormonal effects of the 300 μg norethisterone minipill. 1. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration. Contraception. 23:1980;585-605.
12. Weisberg E., Fraser I.S., Mishell D.R. Jr, Lacarra M., Bardin C.W. The acceptability of a combined estrogen-progestogen contraceptive vaginal ring. Contraception. 51:1995;39-44.
13. Weisberg E., Fraser I.S., Mishell D.R. Jr, et al. Efficacy, bleeding patterns and side effects of a one-year contraceptive vaginal ring. Contraception. 59:1999;311-318.
14. Weisberg E., Fraser I.S., Lacarra M., Mishell D.R. Jr, Jackanicz T. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. Contraception. 56:1997;233-240.